Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index
暂无分享,去创建一个
Kujtim Latifi | Eduardo G Moros | Jan Poleszczuk | Heiko Enderling | Rachel Walker | Jimmy J Caudell | E. Moros | K. Latifi | H. Enderling | J. Poleszczuk | R. Walker | J. Caudell
[1] Ping Wang,et al. A Mathematical Model of Tumor Volume Changes during Radiotherapy , 2013, TheScientificWorldJournal.
[2] Kujtim Latifi,et al. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation , 2015, Radiation Oncology.
[3] John M. L. Ebos,et al. Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth , 2014, PLoS Comput. Biol..
[4] T. Whelan. Use of conventional radiation therapy as part of breast-conserving treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] V. Quaranta,et al. Integrative mathematical oncology , 2008, Nature Reviews Cancer.
[6] Eddie Barendsen,et al. 21 years of Biologically Effective Dose , 2022 .
[7] C. Branch,et al. Mechanisms of Injury to Normal Tissue after Radiotherapy: A Review , 2014, Plastic and reconstructive surgery.
[8] Neil F. Johnson,et al. Model for in vivo progression of tumors based on co-evolving cell population and vasculature , 2011, Scientific reports.
[9] L. Hlatky,et al. Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. , 2013, Cancer research.
[10] K. Cease,et al. Time to treatment in patients with stage III non-small cell lung cancer. , 2009, International journal of radiation oncology, biology, physics.
[11] R. Allison,et al. Radiation oncology: physics advances that minimize morbidity. , 2014, Future oncology.
[12] M. Bernstein,et al. Radiotherapy for brain tumors , 1994, CA: a cancer journal for clinicians.
[13] Hana M. Dobrovolny,et al. Differences in predictions of ODE models of tumor growth: a cautionary example , 2016, BMC Cancer.
[14] Brian O'Sullivan,et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.
[15] Philip Hahnfeldt,et al. Quantitative Modeling of Tumor Dynamics and Radiotherapy , 2010, Acta biotheoretica.
[16] T. Dilling,et al. Altered fractionation schedules in radiation treatment: a review. , 2014, Seminars in oncology.
[17] I. Lax,et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. , 2003, Lung cancer.
[18] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[19] F. J. Richards. A Flexible Growth Function for Empirical Use , 1959 .
[20] P. Hahnfeldt,et al. The Importance of Spatial Distribution of Stemness and Proliferation State in Determining Tumor Radioresponse , 2009 .
[21] Thomas E Yankeelov,et al. Toward a science of tumor forecasting for clinical oncology. , 2015, Cancer research.
[22] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[23] G. Buttazzo,et al. Selecting Radiotherapy Dose Distributions by Means of Constrained Optimization Problems , 2014, Bulletin of mathematical biology.
[24] K Hendrickson,et al. Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach , 2010, Physics in medicine and biology.
[25] Zhihui Wang,et al. Cancer dissemination: a consequence of limited carrying capacity? , 2006, Medical hypotheses.
[26] Philip Hahnfeldt,et al. The Tumor Growth Paradox and Immune System-Mediated Selection for Cancer Stem Cells , 2013, Bulletin of mathematical biology.
[27] Michael Meyer-Hermann,et al. Spatio-Temporal Dynamics of Hypoxia during Radiotherapy , 2015, PloS one.
[28] Eduardo G. Moros,et al. Depend on Activated T-cell Traf fi cking and Distribution between Metastatic Lesions , 2016 .
[29] Nandita Mitra,et al. Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. , 2016, Oral oncology.
[30] J. Folkman,et al. SELF-REGULATION OF GROWTH IN THREE DIMENSIONS , 1973, The Journal of experimental medicine.
[31] P. Vaupel,et al. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.
[32] Philip Gerlee,et al. The model muddle: in search of tumor growth laws. , 2012, Cancer research.
[33] Masahiro Hiraoka,et al. Microenvironment and Radiation Therapy , 2012, BioMed research international.
[34] Mark A. J. Chaplain,et al. Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model , 2013, PLoS Comput. Biol..
[35] S. Jonathan Chapman,et al. Mathematical Models of Avascular Tumor Growth , 2007, SIAM Rev..
[36] M. Gapany. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer , 2011 .
[37] H M Byrne,et al. Growth of nonnecrotic tumors in the presence and absence of inhibitors. , 1995, Mathematical biosciences.
[38] S. Schnell,et al. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies , 2006, Theoretical Biology and Medical Modelling.
[39] A. Anderson,et al. The evolution of carrying capacity in constrained and expanding tumour cell populations , 2014, Physical biology.